X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
SHASUN PHARMACEUTICALS LTD. Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

SHASUN PHARMACEUTICALS LTD.  (SHSCH)


Here is the latest financial fact sheet of SHASUN PHARMA. For more details, see the SHASUN PHARMA quarterly results and SHASUN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
shasun pharma - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 428.9       No. of shares m 60.10
    Mkt Cap Rs m 25,774       % ch % 5.5
    Vol '000 79.8       % ch week % 11.9
    P/E X 123.9       % ch 1-mth % 7.4
    P/CF X 28.8       % ch 12-mth % 102.2
    EPS (TTM) Rs 3.5       52 week H/L Rs 432.1/211.6
(As on Nov 17, 2015 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-10
*
12
Mar-11
*
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs541019218694 
Low Rs1249386046 
Sales per share (Unadj.) Rs158.4171.9193.5191.6214.2 
Earnings per share (Unadj.) Rs0.8-2.918.29.45.3 
Diluted earnings per shareRs0.6-2.416.78.85.0 
Cash flow per share (Unadj.) Rs8.64.825.618.715.8 
Dividends per share (Unadj.) Rs1.000.302.401.501.00 
Adj. dividends per shareRs0.800.242.201.410.94 
Dividend yield (eoy) %3.00.43.71.21.4 
Book value per share (Unadj.) Rs24.417.340.247.753.3 
Adj. book value per shareRs19.614.036.844.950.3 
Shares outstanding (eoy) m48.3148.5455.1256.6256.62 
Bonus/Rights/Conversions  -ESOPPIPI- 
Price / Sales ratio x0.20.40.30.60.3 
Avg P/E ratio x42.4-25.83.613.113.1 
P/CF ratio (eoy) x3.815.52.56.64.4 
Price / Book Value ratio x1.44.31.62.61.3 
Dividend payout %128.5-10.313.216.018.7 
Avg Mkt Cap Rs m1,5943,6413,5836,9643,958 
No. of employees `0001.5NA1.5NANA 
Total wages/salary Rs m1,4031,4321,5941,8662,164 
Avg. sales/employee Rs Th5,278.9NM7,109.3NMNM 
Avg. wages/employee Rs Th967.7NM1,062.7NMNM 
Avg. net profit/employee Rs Th25.9NM670.5NMNM 
  INCOME DATA
Net Sales Rs m7,6548,34510,66410,84812,127 
Other income Rs m221220130183229 
Total revenues Rs m7,8758,56410,79411,03012,356 
Gross profit Rs m2927151,2301,1021,009 
Depreciation Rs m379376406527594 
Interest Rs m301323437255415 
Profit before tax Rs m-167236517504230 
Minority Interest Rs m00000 
Prior Period Items Rs m0-408000 
Extraordinary Inc (Exp) Rs m187028000 
Tax Rs m-18-30-209-26-73 
Profit after tax Rs m38-1411,006530302 
Gross profit margin %3.88.611.510.28.3 
Effective tax rate %10.5-12.8-40.5-5.2-31.7 
Net profit margin %0.5-1.79.44.92.5 
  BALANCE SHEET DATA
Current assets Rs m3,8863,7254,7925,3126,884 
Current liabilities Rs m2,0764,7465,5456,4918,456 
Net working cap to sales %23.6-12.2-7.1-10.9-13.0 
Current ratio x1.90.80.90.80.8 
Inventory Days Days4556475762 
Debtors Days Days92697989108 
Net fixed assets Rs m2,7462,6043,3084,4564,970 
Share capital Rs m9797110113113 
"Free" reserves Rs m9077392,0822,6052,875 
Net worth Rs m1,1788392,2132,7003,020 
Long term debt Rs m3,2646727791,1831,817 
Total assets Rs m6,6356,5458,60510,44513,347 
Interest coverage x0.41.72.23.01.6 
Debt to equity ratio x2.80.80.40.40.6 
Sales to assets ratio x1.21.31.21.00.9 
Return on assets %5.12.816.87.55.4 
Return on equity %3.2-16.845.419.610.0 
Return on capital %7.210.041.219.513.3 
Exports to sales %40.646.846.747.046.4 
Imports to sales %10.813.714.413.714.2 
Exports (fob) Rs m3,1073,9024,9825,1015,622 
Imports (cif) Rs m8261,1471,5351,4841,728 
Fx inflow Rs m3,2834,0115,0835,2585,843 
Fx outflow Rs m8281,3441,7911,7072,173 
Net fx Rs m2,4542,6673,2923,5523,669 
  CASH FLOW
From Operations Rs m 370 590 508 349 398 
From Investments Rs m 96 -321 -773 -1,611 -1,635 
From Financial Activity Rs m -398 -279 316 1,172 1,309 
Net Cashflow Rs m 68 -10 52 -90 71 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for shasun pharmaceuticals ltd.

 Share Holding
Indian Promoters : 39.2%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 3.6%
FIIs : 17.6%
ADR/GDR : 0.0%
Free float : 39.6%
Shareholders : 20,750
Pledged promoter(s) holding : 12.3%
 Company Information
Top
    REGD OFF: Batra Centre, 3rd & 4th Floor, 28, Sardar Patel Road, Guindy, Chennai - 600 032
    E-MAIL: muralikrishna@shasun.com     WEB: www.shasun.com
    TELEPHONE: (044) 4344 6700     FAX: (044) 2235 0278
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Integrated Enterprises, Kences Towers, Ramakrishna St., Chennai-17
    AUDITOR: B. S. R & Co.
CHM: R. Kannan COMP SEC: S. Murali Krishna YEAR OF INC: 1976 BSE CODE: 524552 FV (Rs): 2 DIV YIELD (%): 0.2

More pharmaceuticals Company Fact Sheets:   WYETH LTDTTK HEALTHCAREPANACEA BIOTECHALKEM LABORATORIESSUVEN LIFE


Today's Market

Sensex Closes Firm; NTPC Surges 2.3%(Closing)

Indian share markets continued to trade higher owing to firm global cues with energy stocks leading the gains, while financial stocks and auto stocks bounced back.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why You Should Try SCOREFASTTM Right Now(Daily Profit Hunter)

Mar 10, 2017

Asad Dossani discusses why SCOREFASTM will be a successful trading strategy

4 Things To Watch Out For After Modi's Landslide Win In UP Polls(Outside View)

Mar 15, 2017

PersonalFN explains why you need to wary while investing in equities despite Modi's UP win.

More

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHASUN PHARMA

SHASUN PHARMA - SUVEN LIFE COMPARISON

Compare Company With Charts

COMPARE SHASUN PHARMA WITH

MARKET STATS